Pain Management

Citing a rare yet serious risk of slowed breathing, the FDA is evaluating the use of the opioid pain medication tramadol (Ultram, Ultram ER, Conzip) in the pediatric population.

Pregabalin and gabapentin are often considered first-line treatments for various neuropathic pain syndromes, generally irrespective of cause.

Draft guidelines from the US Centers for Disease Control and Prevention (CDC) could sharply reduce the role opioids play in primary care-based pain management.

Through a partnership between the St. Louis College of Pharmacy (STLCOP) and Washington University School of Medicine in St. Louis, the new Center for Clinical Pharmacology in Missouri will work toward improving pain treatment.

This Continuing Education activity is supported by an educational grant from Mallinckrodt.

The US Department of Health and Human Services (HHS) is making it easier for patients with shoulder injury related to vaccine administration (SIRVA) to be compensated for their pain.

The Drug Enforcement Administration (DEA) recently made an appearance at a state pharmacy board meeting to appease pharmacists' fears of a crackdown on pharmacies.

Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes may cause severe and disabling joint pain, the FDA has warned.

The FDA has accepted Allergan's resubmission to approve the use of onabotulinumtoxinA (Botox) for lower limb spasticity in adults.

A pharmacist's perspective of OxyContin's approval for use in patients ages 11 to 16.

The FDA has expanded the use of the powerful painkiller oxycodone (OxyContin) for children as young as 11.

Pharmacists can have a positive impact by identifying and helping patients in pain.

Pain is associated with a variety of injuries and diseases, and is often the disease itself.

The low back, also known as the lumbosacral region, is a complex structure of interconnected and overlapping tendons, ligaments, muscles, nerves, joints, and discs.

The Centers for Disease Control and Prevention estimates that about 2% of the population is affected by fibromyalgia.

Migraines are usually unilateral in nature, with throbbing associated with them and an aura prior to onset, which alerts patients to the migraine.

Pain is a common complaint for which patients elect to use one of the various nonprescription analgesics currently on the market.

The recent explosion in deaths from opioids seems to be different from any previous observations.

Pharmacists can play pivotal roles in pain management, such as counseling patients on properly selecting and using analgesics.

Prescriptions for opioids from the emergency room may be deescalated.

Is there a need to strengthen the labeling of topical NSAIDs that clearly lack systemic therapeutic or toxic levels?

Pharmacists can help minimize risk for patients using pain medications.

Counseling family members about hospice medications requires compassion and empathy.

The FDA approved a 2.9-mg/0.71-mg dosage strength of Orexo's sublingual buprenorphine/naloxone (Zubsolv).

The FDA today approved eluxadoline and rifaximin to treat irritable bowel syndrome with diarrhea.